Does Zelboraf Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- P-GLYCOPROTEIN (P-GP) INHIB/COLCHICINE (CARDIOPROTECTION)
- CYP1A2 INHIBITORS/FEZOLINETANT
- SELECTED CYP1A2 INHIBITORS/RASAGILINE (> 0.5 MG)
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- VEMURAFENIB/QT PROLONGING AGENTS
- VEMURAFENIB/STRONG CYP3A4 INDUCERS; RIFABUTIN
- VEMURAFENIB/STRONG CYP3A4 INHIBITORS
- VEMURAFENIB/STRONG CYP3A4 INHIBITORS THAT PROLONG QT
- VEMURAFENIB/STRONG CYP3A4 INDUCERS THAT PROLONG QT
- P-GLYCOPROTEIN (P-GP) INHIBITORS/VINCRISTINE
- CYP3A4 INDUCERS/ZURANOLONE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/PRALSETINIB
- CYP3A4 INDUCERS/ERLOTINIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/BILASTINE
- CYP3A4 INDUCERS/ATOGEPANT
- P-GLYCOPROTEIN (P-GP) INHIBITORS/DOXORUBICIN
- P-GP INHIBITORS/RIMEGEPANT
- P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
- P-GP OR BCRP INHIBITORS THAT PROLONG QT/PAZOPANIB
- CYP3A4 INDUCERS/LUMATEPERONE
- VEMURAFENIB/CLOZAPINE
- P-GP INHIBITORS THAT PROLONG QT/ORAL LEFAMULIN
- WEAK CYP2D6 INHIBITORS/ELIGLUSTAT
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/VENETOCLAX
- P-GLYCOPROTEIN (P-GP) INHIBITORS/COLCHICINE
- VEMURAFENIB/DIGOXIN
- POSSIBLE QT PROLONGING AGENTS/ANAGRELIDE
- VEMURAFENIB/SELECTED CYP1A2 SUBSTRATES
- POSSIBLE QT PROLONGING AGENTS/DRONEDARONE
- POSSIBLE QT PROLONGING AGENTS/ARTEMETHER-LUMEFANTRINE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/DABIGATRAN
- POSSIBLE QT PROLONGING AGENTS/DISOPYRAMIDE
- POSSIBLE QT PROLONGING AGENTS/CISAPRIDE
- SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
- POSSIBLE QT PROLONGING AGENTS/SERTINDOLE
- POSSIBLE QT PROLONGING AGENTS/DROPERIDOL
- POSSIBLE QT PROLONGING AGENTS/LEVOMETHADYL
- POSSIBLE QT PROLONGING AGENTS/SPARFLOXACIN
- POSSIBLE QT PROLONGING AGENTS/HALOFANTRINE
- POSSIBLE QT PROLONGING AGENTS/PIMOZIDE
- POSSIBLE QT PROLONGING AGENTS/BEPRIDIL
- QT PROLONGING AGENTS/THIORIDAZINE
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- VEMURAFENIB/POSSIBLE QT PROLONGING AGENTS
- POSSIBLE QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- QT PROLONGING AGENTS/ETRASIMOD
- QT PROLONGING AGENTS/GEPIRONE
- QT PROLONGING AGENTS/TUCIDINOSTAT
- MODERATE AND WEAK CYP3A4 INDUCERS THAT PROLONG QT/TACROLIMUS
- STRONG CYP1A2 OR CYP2D6 INHIBITORS/FENFLURAMINE
- QT PROLONGING AGENTS/TRICLABENDAZOLE
- POSSIBLE QT PROLONGING AGENTS/PACRITINIB
- QT PROLONGING AGENTS/TOLTERODINE
- SELECTED POSSIBLE QT PROLONGING AGENTS/INTRAVENOUS LEFAMULIN
- QT PROLONGING AGENTS/OZANIMOD
- QT PROLONGING AGENTS/PONESIMOD
- QT PROLONGING AGENTS/SIPONIMOD
- POSSIBLE QT PROLONGING AGENTS/FEXINIDAZOLE
- QT PROLONGING AGENTS/GALANTAMINE
- SELECTED WEAK CYP2D6 INHIBITORS/TAMOXIFEN
- POSSIBLE QT PROLONGING AGENTS/LEVOMEPROMAZINE
- POSSIBLE QT PROLONGING AGENTS/SELPERCATINIB
- POSSIBLE QT PROLONGING AGENTS/OXALIPLATIN
- QT PROLONGING AGENTS/OSILODROSTAT
- QT PROLONGING AGENTS/AMISULPRIDE
- MODERATE AND WEAK CYP3A4 INDUCERS/UBROGEPANT
- POSSIBLE QT PROLONGING AGENTS/ENTRECTINIB
- QT PROLONGING AGENTS/PITOLISANT
- QT PROLONGING AGENTS/GILTERITINIB
- POSSIBLE QT PROLONGING AGENTS/GLASDEGIB
- SELECT P-GP INHIBITORS/EDOXABAN (<= 30 MG)
- POSSIBLE QT PROLONGING AGENTS/TRAZODONE (< 100 MG)
- POSSIBLE QT PROLONGING AGENTS/LOFEXIDINE
- POSSIBLE QT PROLONGING AGENTS/MACIMORELIN
- POSSIBLE QT PROLONGING AGENTS/INOTUZUMAB OZOGAMICIN
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/BETRIXABAN
- QT PROLONGING AGENTS/EFAVIRENZ
- POSSIBLE QT PROLONGING AGENTS/HYDROXYZINE
- POSSIBLE QT PROLONGING AGENTS/PIMAVANSERIN
- POSSIBLE QT PROLONGING AGENTS/OSIMERTINIB
- SELECT P-GP INHIBITORS/EDOXABAN (> 30 MG)
- POSSIBLE QT PROLONGING AGENTS/LENVATINIB
- POSSIBLE QT PROLONGING AGENTS/DELAMANID
- MODERATE CYP1A2 INHIBITORS/PIRFENIDONE
- SELECTED MODERATE-WEAK CYP3A4 INDUCERS/EXEMESTANE
- POSSIBLE QT PROLONGING AGENTS/TRAZODONE (>= 100 MG)
- P-GLYCOPROTEIN (P-GP) INHIBITORS/AFATINIB
- POSSIBLE QT PROLONGING AGENTS/BEDAQUILINE
- QT PROLONGING AGENTS/PASIREOTIDE
- POSSIBLE QT PROLONGING AGENTS/SORAFENIB
- QT PROLONGING AGENTS/FINGOLIMOD
- POSSIBLE QT PROLONGING AGENTS/CRIZOTINIB
- POSSIBLE QT PROLONGING AGENTS/GADOFOSVESET
- SELECTED CYP1A2 INHIBITORS/RASAGILINE (<= 0.5 MG)
- POSSIBLE QT PROLONGING AGENTS/ILOPERIDONE
- POSSIBLE QT PROLONGING AGENTS/TOREMIFENE
- MODERATE CYP3A4; P-GP INHIBITORS/EVEROLIMUS
- POSSIBLE QT PROLONGING AGENTS/ZUCLOPENTHIXOL
- POSSIBLE QT PROLONGING AGENTS/NILOTINIB
- POSSIBLE QT PROLONGING AGENTS/PALIPERIDONE
- QT PROLONGING AGENTS/RANOLAZINE
- POSSIBLE QT PROLONGING AGENTS/IVABRADINE
- POSSIBLE QT PROLONGING AGENTS/AMIODARONE
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/ETOPOSIDE
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.